Jones Day is acting for Celgene Corporation in multiple cases brought by Accord Healthcare in the UK High Court (patents court) in relation to Celgene's patents concerning its best-selling drug, Revlimid®. The Firm is also assisting Celgene with coordination respecting Revlimid® patent protection across Europe.

Contact: Anthony M. Insogna, Alastair J. McCulloch